The authors report a case of IIH that was successfully resolved with digoxin after standard avenues of therapy were exhausted.
The condition is difficult to diagnose because it may involve specialist consultations (eg, neurology, ophthalmology) or procedures (eg, lumbar puncture). Neuroimaging studies do not show evidence of hydrocephalus, masses, or vascular or structural abnormalities. Cerebrospinal fluid composition is usually normal.
2 At a rate of 7.9 per 100,000, obese females of childbearing age are disproportionately affected by IIH. 3 The pathophysiologic process of IIH is uncertain. One theory posits that there is resistance of CSF outflow at the level of the arachnoid granulations. Other theories attribute the condition to abnormalities of the cerebral venous outflow or a change in sodium and water retention mechanisms. 4 Another cause may be problems with vitamin A metabolism 5 or obesity-related increased abdominal pressure and intracranial venous pressure. 5, 6 Management of IIH involves both medical and surgical modalities. If a patient is obese, weight loss is encouraged, and acetazolamide and topiramate 4 are frequently prescribed, as is furosemide. 7 A physician may also perform serial lumbar punctures to decrease CSF pressure.
Patients whose conditions cannot be managed with these methods, or whose vision is failing, have surgical options, including CSF shunting and optic nerve sheath fenestration (ONSF). 8 However, these treatment options have some risks. Shunting can be highly effective, but the shunts often need to be revised or replaced, especially for obese patients. 9 Whereas many patients experience relief from headaches with shunts, Rosenberg et al 10 found that only 14 of 37 patients remained "cured" after a single
CASE REPORT
The We discussed the need for a change in treatment because of her vision problems and worsening headaches.
Finding an appropriate medication was a challenge because of her allergies to acetazolamide and furosemide.
She had been trying to lose weight for years but had also been taking steroids, which can cause weight gain, for her rheumatologic disorders. We presented the options of a CSF shunt or ONSF. However, the patient refused all surgical procedure. Physicians may use ONSF to preserve or stabilize a patient's vision, but the procedure often does not alleviate headache symptoms. 11 We report a case of IIH that demonstrates the effects of digoxin, a medication that may benefit patients for whom other treatments have failed or who are unable or unwilling to undergo surgical procedures. The patient lost 14 lb in the first 6 months of treatment, a result that correlates with that of Hannerz, 6 who found that treatment with digoxin caused weight loss and a decrease in CSF pressure in obese patients. Although our patient continued to lose weight (78 lb during the course of 4 years), she also experienced some gastrointestinal motility problems during the same time span.
Report of Case
Therefore, it cannot be said whether digoxin is responsible for the patient's weight loss.
Conclusion
In patients with IIH and complicated medical conditions, physicians should consider digoxin. Even though the mechanism of action is not well understood, it clearly has benefits in this group of patients.
